doxycycline without perscription canadian https://www.antibioticsonlinerx.com/buy-doxycycline-online-cheap/
Chemicals Stocks

Praxair Inc Valuation – March 2018 $PX

Company Profile (obtained from Marketwatch): Praxair, Inc. engages in designs, engineers, manufactures, and operates facilities that produce and distribute industrial gases. It operates through the following segments: North America, Europe, South America, Asia, and Surface Technologies. The North America segment offers production facilities in the U.S., Canada, and Mexico. The Europe segment includes production facilities in Italy, Spain, Germany, the Benelux region, Scandinavia, and Russia which include cryogenic air separation plants. The South America segment covers cryogenic air separation plants, located in Brazil. The Asia segment comprises of production facilities located in China, Korea, India, and Thailand, which are cryogenic air separation plants. The Surface Technologies segment consists of coating services and manufactures coating equipment. The company was founded in 1907 and is headquartered in Danbury, CT.
PX Chart

PX data by YCharts

 

Downloadable PDF version of this valuation:

ModernGraham Valuation of PX – March 2018

Stage 1: Is this company suitable for the Defensive Investor or the Enterprising Investor?

What kind of Intelligent Investor are you?

Defensive Investor; must pass 6 out of the following 7 tests.
1. Adequate Size of the Enterprise Market Cap > $2Bil $43,990,816,202 Pass
2. Sufficiently Strong Financial Condition Current Ratio > 2 0.99 Fail
3. Earnings Stability Positive EPS for 10 years prior Pass
4. Dividend Record Dividend Payments for 10 years prior Pass
5. Earnings Growth Increase of 33% in EPS in past 10 years using 3 year averages at beginning and end 19.17% Fail
6. Moderate PEmg Ratio PEmg < 20 28.47 Fail
7. Moderate Price to Assets PB Ratio < 2.5 OR PB*PEmg < 50 7.43 Fail
Enterprising Investor; must pass 4 out of the following 5 tests, or be suitable for the Defensive Investor.
1. Sufficiently Strong Financial Condition Current Ratio > 1.5 0.99 Fail
2. Sufficiently Strong Financial Condition Debt to NCA < 1.1 -353.77 Fail
3. Earnings Stability Positive EPS for 5 years prior Pass
4. Dividend Record Currently Pays Dividend Pass
5. Earnings Growth EPSmg greater than 5 years ago Fail

 

Stage 2: Determination of Intrinsic Value

EPSmg $5.40
MG Growth Estimate -0.49%
MG Value $40.53
Opinion Overvalued
MG Grade C
MG Value based on 3% Growth $78.24
MG Value based on 0% Growth $45.87
Market Implied Growth Rate 9.99%
Current Price $153.65
% of Intrinsic Value 379.12%

Praxair, Inc. does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings growth over the last ten years, and the high PEmg and PB ratios. The Enterprising Investor has concerns regarding the level of debt relative to the current assets, and the lack of earnings growth over the last five years. As a result, all value investors following the ModernGraham approach should explore other opportunities at this time or proceed cautiously with a speculative attitude.

As for a valuation, the company appears to be Overvalued after seeing its EPSmg (normalized earnings) decline from $5.58 in 2014 to an estimated $5.4 for 2018. This level of demonstrated earnings growth does not support the market’s implied estimate of 9.99% annual earnings growth over the next 7-10 years. As a result, the ModernGraham valuation model, based on the Benjamin Graham value investing formula, returns an estimate of intrinsic value below the price.

At the time of valuation, further research into Praxair, Inc. revealed the company was trading above its Graham Number of $54.63. The company pays a dividend of $3.15 per share, for a yield of 2.1%, putting it among the best dividend paying stocks today. Its PEmg (price over earnings per share – ModernGraham) was 28.47, which was below the industry average of 31.55, which by some methods of valuation makes it one of the most undervalued stocks in its industry. Finally, the company was trading above its Net Current Asset Value (NCAV) of $-38.27.

Praxair, Inc. receives an average overall rating in the ModernGraham grading system, scoring a C.

Stage 3: Information for Further Research

Net Current Asset Value (NCAV) -$38.27
Graham Number $54.63
PEmg 28.47
Current Ratio 0.99
PB Ratio 7.43
Current Dividend $3.15
Dividend Yield 2.05%
Number of Consecutive Years of Dividend Growth 20

Useful Links:

ModernGraham tagged articles Morningstar
Google Finance MSN Money
Yahoo Finance Seeking Alpha
GuruFocus SEC Filings

Most Recent Balance Sheet Figures

Balance Sheet Information 12/1/2017
Total Current Assets $3,285,000,000
Total Current Liabilities $3,307,000,000
Long-Term Debt $7,783,000,000
Total Assets $20,436,000,000
Intangible Assets $3,786,000,000
Total Liabilities $14,418,000,000
Shares Outstanding (Diluted Average) 290,884,000

Earnings Per Share History

EPS History
Next Fiscal Year Estimate $6.32
Dec2017 $4.32
Dec2016 $5.21
Dec2015 $5.35
Dec2014 $5.73
Dec2013 $5.87
Dec2012 $5.61
Dec2011 $5.45
Dec2010 $3.84
Dec2009 $4.01
Dec2008 $3.80
Dec2007 $3.62
Dec2006 $3.00
Dec2005 $2.20
Dec2004 $2.10
Dec2003 $1.77
Dec2002 $1.24
Dec2001 $1.31
Dec2000 $1.13
Dec1999 $1.33
Dec1998 $1.30

Earnings Per Share – ModernGraham History

EPSmg History
Next Fiscal Year Estimate $5.40
Dec2017 $5.05
Dec2016 $5.47
Dec2015 $5.60
Dec2014 $5.58
Dec2013 $5.32
Dec2012 $4.88
Dec2011 $4.39
Dec2010 $3.79
Dec2009 $3.62
Dec2008 $3.27
Dec2007 $2.84
Dec2006 $2.33
Dec2005 $1.90
Dec2004 $1.67
Dec2003 $1.42
Dec2002 $1.25

Recommended Reading:

Other ModernGraham posts about the company

Praxair Inc Valuation – August 2017 $PX
Praxair Inc Valuation – June 2016 $PX
Praxair Inc. Annual Valuation – 2015 $PX

Other ModernGraham posts about related companies

Eastman Chemical Co Valuation – March 2018 $EMN
LyondellBasell Industries NV Valuation – March 2018 $LYB
DowDuPont Inc Valuation – February 2018 $DWDP
Green Plains Inc Valuation – Initial Coverage $GPRE
PolyOne Corp Valuation – Initial Coverage $POL
Ingevity Corp Valuation – Initial Coverage $NGVT
Praxair Inc Valuation – August 2017 $PX
Albemarle Corp Valuation – March 2017 $ALB
Sensient Technologies Corp Valuation – Initial Coverage $SXT
Quaker Chemical Corp Valuation – Initial Coverage $KWR

Disclaimer:

The author did not hold a position in any company mentioned in this article at the time of publication and had no intention of changing that position within the next 72 hours.  See my current holdings here.  This article is not investment advice; any reader should speak to a registered investment adviser prior to making any investment decisions.  ModernGraham is not affiliated with the company in any manner.  Please be sure to review our detailed disclaimer.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back To Top